Cardima Receives CE Mark Approval for its Surgical Ablation Probe with Stabilization Sheath

Cardima, Inc., a medical device company focused on the treatment of atrial fibrillation and manufacturer of the Cardima Surgical Ablation System, today announced that it has received CE Mark approval for its Surgical Ablation Probe with Stabilization Sheath.

Abbott Initiates U.S. Study of Absolute Pro™ Peripheral Stent System for Iliac Artery Disease

Abbott today announced the initiation of MOBILITY, a clinical trial studying the safety and efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in patients with iliac artery disease.

Small Bone Innovations, Inc. Strengthens Senior Management & Announces Formation of Executive Committee

Small Bone Innovations, Inc., a single-source provider of innovation, products, technology and education for the small bone & joint sector of the orthopedics industry, announced that it has strengthened its Senior Management and also formed its Executive Management Team.

Sorin Group And Orange Business Services To Develop Remote Monitoring Solution For Cardiac Patients

Sorin Group and Orange Business Services today announced an agreement to develop and service a remote monitoring solution for patients implanted with cardiac rhythm management devices.

Medtronic Announces International Market Release of Driver Sprint RX Coronary Stent System

Medtronic, Inc. today began the international launch of the Driver Sprint RX Coronary Stent System, which received the CE Mark in February 2009 and is planned to be commercially available in more than 100 countries worldwide.

Thrombus Aspiration With Medtronic’s Export Catheter May Improve Outcomes For Heart Attack Patients

Removing thrombus from coronary arteries with the Export Aspiration Catheter from Medtronic, Inc., before implanting a stent in patients suffering a specific kind of heart attack, “results in excellent clinical outcomes,” at one year, according to new data released today at the American College of Cardiology meeting.

Medtronic’s Endeavor Stent Shows Consistent And Sustained Safety And Effectiveness Benefits At Two Years

New data released at the 2009 American College of Cardiology meeting demonstrated exceptional long-term safety and effectiveness results for the Endeavor drug-eluting coronary stent from Medtronic, Inc.

Most read

Latest

^